Fibricheck

fibricheck

Bringing certified digital health solutions to everyday practice by offering user-friendly, high quality and proven mobile applications at a low cost, supported by EIT Health

Atrial fibrillation (AFib) is a silent killer, affecting 10 million people in Europe alone. The population at risk is growing at an alarming rate; AFib is the cause of over 20% of all strokes and can lead to heart failure, kidney problems and coronary heart disease.

Although difficult to detect, FibriCheck overcomes current technology challenges by requiring only a mobile device that enables users to detect AFib and take preventive action.


Want to know more about Fibricheck?

Website: fibricheck.com

EIT Venture Award winner FibriCheck earns FDA approval